内皮细胞中ENO2调控的糖酵解参与FGF2诱导的视网膜新生血管形成
该研究利用氧诱导视网膜病变小鼠模型和人视网膜微血管内皮细胞,探讨FGF2在视网膜新生血管形成中的作用及机制。FGF2在模型鼠视网膜中显著上调并增强内皮细胞成管、迁移和增殖能力;蛋白质组学发现糖酵解通路显著上调,ENO2水平升高,敲低ENO2可减弱糖酵解和血管生成;ENO2抑制剂AP-Ⅲ-a4在体内外减轻血管生成。
要点
- FGF2在氧诱导视网膜病变小鼠视网膜中显著上调,并增强人视网膜微血管内皮细胞的成管、迁移和增殖能力。
- FGF2刺激内皮细胞后糖酵解通路显著上调,ENO2水平升高,敲低ENO2可减弱糖酵解和血管生成过程。
- ENO2抑制剂AP-Ⅲ-a4在体内和体外均减轻血管生成,提示ENO2可能成为病理性新生血管的治疗靶点。
核心结论
- ENO2介导的糖酵解在FGF2诱导的血管生成中起关键作用,ENO2可能成为管理病理性新生血管的有前景的治疗靶点。
研究设计与样本
- 研究采用氧诱导视网膜病变小鼠模型研究视网膜新生血管的发病机制。
- 使用免疫荧光定量视网膜新生血管,采用数据非依赖采集蛋白质组学定量FGF2刺激的人视网膜微血管内皮细胞中的差异表达蛋白并分析相关通路。
- 采用qRT-PCR和蛋白质印迹检测基因的mRNA和蛋白表达水平,通过Transwell、EdU和成管实验测定人视网膜微血管内皮细胞的血管生成能力。
主要发现
- FGF2在氧诱导视网膜病变小鼠模型视网膜组织中显著上调,并在体外明显增强人视网膜微血管内皮细胞的成管、迁移和增殖能力。
- 蛋白质组学分析鉴定出FGF2刺激内皮细胞后287个差异表达蛋白,以糖酵解通路显著上调为特征。
- FGF2刺激后ENO2水平升高,敲低ENO2导致糖酵解活性减弱和血管生成过程受损。
- ENO2抑制剂AP-Ⅲ-a4在体内和体外均减轻血管生成。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Ocular neovascularization is a major cause of blindness. Although fibroblast growth factor-2 (FGF2) has been implicated in the pathophysiology of angiogenesis, the underlying mechanisms remain incompletely understood. The purpose of this study was to investigate the role of FGF2 in retinal neovascularization and elucidate its underlying mechanisms. METHODS: The oxygen-induced retinopathy mouse model was used to study the pathogenesis of retinal neovascularization. Immunofluorescence was used to quantify the neovascularization in retina. Data-independent acquisition proteomics were performed to quantify differentially expressed proteins in human retinal microvascular endothelial cells stimulated with FGF2 and associated pathways were analyzed. We carried out qRT-PCR and Western Blot assays to detect the expression of genes at mRNA and protein levels. The angiogenesis abilities of human retinal microvascular endothelial cells were measured by transwell, EdU and tube formation assays. RESULTS: FGF2 was significantly upregulated in retinal tissues of the oxygen-induced retinopathy mouse model and it markedly enhanced tube formation, migration, and proliferation abilities of human retinal microvascular endothelial cells in vitro. The proteomic analysis identified 287 differentially expressed proteins in endothelial cells in response to FGF2 stimulation, characterized by a notable upregulation of the glycolysis pathway, among which we confirmed that the enolase 2 (ENO2) levels were elevated after FGF2 stimulation, and its knockdown resulted in diminished glycolytic activity and impaired angiogenic processes. Furthermore, the use of the ENO2 inhibitor AP-Ⅲ-a4 alleviated angiogenesis in vivo and in vitro. CONCLUSIONS: Our findings underscore the pivotal role of ENO2-mediated glycolysis in FGF2-induced angiogenesis, suggesting that ENO2 may serve as a promising therapeutic target for managing pathological neovascularization.
引用
- Liao D, Wang J, Zhang X, et al. ENO2-Regulated Glycolysis in Endothelial Cells Contributes to FGF2-Induced Retinal Neovascularization. Invest Ophthalmol Vis Sci. 2025. PMID: 39854009. doi:10.1167/iovs.66.1.58
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。